Next |
home / stock / indp / indp message board
Subject | By | Source | When |
---|---|---|---|
$INDP MomentumIts gaining | Surfacetite | investorshub | 05/08/2023 8:37:38 AM |
$INDP got some short data | DeadCellShadix | investorshub | 05/08/2023 1:32:26 AM |
Price gaining | Surfacetite | investorshub | 05/07/2023 3:23:16 PM |
$INDP MomentumIts now last trade up | MonstaGains | investorshub | 05/03/2023 4:25:58 PM |
The gaining up | MonstaGains | investorshub | 05/01/2023 7:51:29 PM |
Good read | wickerman | investorshub | 04/30/2023 8:11:52 AM |
$INDP what does this mean? | MonstaGains | investorshub | 04/28/2023 12:31:52 PM |
short squeeze signal | MonstaGains | investorshub | 04/27/2023 6:10:32 AM |
The trading | DeadCellShadix | investorshub | 04/25/2023 1:24:40 PM |
$INDP Price gaining | TheFinalCD | investorshub | 04/23/2023 10:48:56 PM |
$INDP and the shorts continue | cityimport | investorshub | 04/23/2023 2:57:16 AM |
Good read | madras50 | investorshub | 04/22/2023 2:54:02 AM |
Time for a bounce? | madras50 | investorshub | 04/22/2023 2:02:56 AM |
MomentumIts now | TheFinalCD | investorshub | 04/21/2023 2:32:27 PM |
$INDP MomentumIts trading | madras50 | investorshub | 04/21/2023 3:03:40 AM |
Price gaining last trade up | subslover | investorshub | 04/19/2023 10:02:44 PM |
This thing warming up | Jess070283 | investorshub | 04/19/2023 8:38:55 PM |
MomentumIts now last up | TheFinalCD | investorshub | 04/19/2023 4:55:54 AM |
What are we thinking here | heyitsmeagain | investorshub | 04/18/2023 9:48:51 PM |
Long and strong lets hope im right | Zardiw | investorshub | 04/18/2023 9:44:26 AM |
News, Short Squeeze, Breakout and More Instantly...
Indaptus Therapeutics Inc. Company Name:
INDP Stock Symbol:
NASDAQ Market:
Indaptus Therapeutics Inc. Website:
- Chief Scientific Officer Dr. Newman to present initial clinical data that further validates Company’s “Pulse-Prime” hypothesis - Dr. Newman also named Chair of the Summit NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a...
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced that its Chief Medical Officer, Roger Waltzman, M.D., will present an update on ...
Latest data from first and second cohorts support Company’s 'pulse-prime' approach, demonstrating rapid clearance, broad immune activation, and encouraging safety profile Poster Presented at American Society of Clinical Oncology Annual Meeting NEW YORK, June 03, 2024 (GLOBE...